Neuroimmune system-mediated renal protection mechanisms Tsuyoshi Inoue Invited review article Open access 20 April 2021 Pages: 915 - 924
Pathology and pathogenic pathways in fabry nephropathy Sandro FeriozziPaula Rozenfeld Review article 26 March 2021 Pages: 925 - 934
Hepatocyte growth factor ameliorates methylglyoxal-induced peritoneal inflammation and fibrosis in mouse model Haruhito YoshimineShiroh TanoueAkio Ido Original article 28 April 2021 Pages: 935 - 943
A chalcone derivative retards renal cyst enlargement by inhibiting fluid secretion and cell proliferation in an in vitro model of polycystic kidney disease Peerachat VeeraphanWarinthorn ChavasiriChaowalit Yuajit Original article 31 May 2021 Pages: 944 - 952
Nutritional status and risk of contrast-associated acute kidney injury in elderly patients undergoing percutaneous coronary intervention Xiaoqi WeiHanchuan ChenFeng Jiang Original article Open access 12 April 2021 Pages: 953 - 962
Regional citrate anti-coagulation dose titration: impact on dose of continuous renal replacement therapy Charles Jun Han NgCheng Boon PohChang Yin Chionh Original article 22 April 2021 Pages: 963 - 969
Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD) Kiyotaka UchiyamaToshio MochizukiSatoru Muto Original article 29 April 2021 Pages: 970 - 980
The association between renal elasticity evaluated by Real-time tissue elastography and renal fibrosis Ayu MakitaTomoaki NagaoOsamu Yamaguchi Original article 08 May 2021 Pages: 981 - 987
Utility of remission criteria for the renal prognosis of IgA nephropathy Keiichi MatsuzakiHitoshi SuzukiYusuke Suzuki Original article Open access 11 May 2021 Pages: 988 - 995
Nationwide survey of the coronavirus disease 2019 prevention and treatment systems for kidney disease patients: a study of Japanese Society of Nephrology-certified educational facilities Yuka SugawaraMasao Iwagamiand the Japanese Society of Nephrology Original article 31 May 2021 Pages: 996 - 1002
Effect of tolvaptan in Japanese patients with autosomal dominant polycystic kidney disease: a post hoc analysis of TEMPO 3:4 and TEMPO Extension Japan Satoru MutoTadashi OkadaShigeo Horie Original article Open access 04 June 2021 Pages: 1003 - 1010
Factors predicting the recovery from acute kidney injury in children with primary nephrotic syndrome Na GuanYong YaoBaige Su Original article 15 May 2021 Pages: 1011 - 1017
Clinical and histological features in pediatric and adolescent/young adult patients with renal disease: a cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR) Maki UrushiharaHiroshi Satothe Committee for Renal Biopsy and Disease Registry of the Japanese Society of Nephrology Original article 28 May 2021 Pages: 1018 - 1026
Distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome Tetsuro TamaiKaori KamijoKazuo Itabashi Original article Open access 01 June 2021 Pages: 1027 - 1034
Low-GDP, pH-neutral solutions preserve peritoneal endothelial glycocalyx during long-term peritoneal dialysis Naoya SugiyamaMitsuhiro TawadaYasuhiko Ito Original article 17 May 2021 Pages: 1035 - 1046
Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effects Nobuo Nagano Letter to the editor 01 May 2021 Pages: 1047 - 1048
Correction to: Pleiotropic effect of erythropoiesis‑stimulating agents on circulating endothelial progenitor cells in dialysis patients Takashi NaitoManabe ShunKosaku Nitta Correction 05 July 2021 Pages: 1049 - 1050